Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARA | P10276 | 9/20 | 0.39 |
| ▸ | RARB | P10826 | 9/20 | 0.39 |
| ▸ | RARG | P13631 | 9/20 | 0.39 |
| ▸ | PGR | P06401 | 7/20 | 0.37 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16559084 | 0.77 | PGR (0.49) | RARARARBRARGPGRHTT | |
| SCHEMBL3781710 | 0.77 | GAA (0.34) | PGRTP53HCAR3ALDH1A1 | |
| SCHEMBL3783532 | 0.71 | KMT2A (0.34) | RARARARBRARGPGRALDH1A1 | |
| SCHEMBL2590921 | 0.71 | KDM4E (0.33) | ALDH1A1CYP3A4 | |
| SCHEMBL5214499 | 0.69 | RXRA (0.39) | RARARARBRARGALDH1A1CYP3A4 | |
| SCHEMBL11503523 | 0.68 | RARA (0.46) | RARARARBRARGPGRALDH1A3 | |
| SCHEMBL12288724 | 0.68 | PGR (0.48) | PGRNR3C1ARALDH1A1 | |
| SCHEMBL3785141 | 0.67 | MEN1 (0.32) | RARARARBRARGCYP3A4 | |
| SCHEMBL3787932 | 0.67 | SLC6A2 (0.33) | — | |
| SCHEMBL12850053 | 0.67 | PGR (0.47) | PGRTP53HTTNR3C1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | RARA 3419/4885RARB 2908/4885RARG 3983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.